Infliximab-induced psoriasis during therapy for Crohn's disease

Imagem de Miniatura
Arquivos
art_ROMITI_Infliximab_induced_psoriasis_during_therapy_for_Crohn_s_2012.PDF (613.32 KB)
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE BV
Autores
STEINWURZ, Flavio
DENADAI, Rafael
SAAD-HOSSNE, Rogerio
QUEIROZ, Maria Luiza
TEIXEIRA, Fabio Vieira
Citação
JOURNAL OF CROHNS & COLITIS, v.6, n.5, p.610-616, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Although therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-THE-induced psoriasis have increasingly been reported, mostly in the setting of rheumatologic diseases. To date, less than 50 cases of infliximab-induced psoriasis in inflammatory bowel disease patients have been described. The present report was aimed at describing two new cases of infliximab-induced psoriasis during therapy for Crohn's disease and at carrying out a review on this intriguing phenomenon.
Palavras-chave
Biological therapy, Crohn's disease, Infliximab, Psoriasis, Tumor necrosis factor-alpha inhibitors
URI
https://observatorio.fm.usp.br/handle/OPI/1307
Referências
  1. Adams David R, 2006, J Drugs Dermatol, V5, P178
  2. Alvarez AA, 2009, AN PEDIATR, V70, P278, DOI 10.1016/j.anpedi.2008.11.013
  3. Angelucci E, 2007, INFLAMM BOWEL DIS, V13, P1059, DOI 10.1002/ibd.20137
  4. Basavaraj KH, 2010, INT J DERMATOL, V49, P1351, DOI 10.1111/j.1365-4632.2010.04570.x
  5. Bordel-Gomez MT, 2009, J EUR ACAD DERMATOL, V23, P444, DOI 10.1111/j.1468-3083.2008.02898.x
  6. Cohen JD, 2007, J RHEUMATOL, V34, P380
  7. Collamer AN, 2008, ARTHRIT RHEUM-ARTHR, V59, P996, DOI 10.1002/art.23835
  8. Collamer AN, 2010, SEMIN ARTHRITIS RHEU, V40, P233, DOI 10.1016/j.semarthrit.2010.04.003
  9. Conklin LS, 2010, NAT REV GASTRO HEPAT, V7, P174, DOI 10.1038/nrgastro.2010.7
  10. Costa-Romero M, 2008, INFLAMM BOWEL DIS, V14, P1462, DOI 10.1002/ibd.20450
  11. de Gannes GC, 2007, ARCH DERMATOL, V143, P223, DOI 10.1001/archderm.143.2.223
  12. English PL, 2009, J CUTAN MED SURG, V13, P40, DOI 10.2310/7750.2008.07080
  13. Fidder H, 2009, GUT, V58, P501, DOI 10.1136/gut.2008.163642
  14. Fiorino G, 2009, ALIMENT PHARM THER, V29, P921, DOI 10.1111/j.1365-2036.2009.03955.x
  15. Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490
  16. Goldstein J, 2010, CLIN GASTROENTEROL H, V8, pXXIV, DOI 10.1016/j.cgh.2010.04.015
  17. Harrison MJ, 2009, ANN RHEUM DIS, V68, P209, DOI 10.1136/ard.2007.087288
  18. Hiremath G, 2011, J PEDIATR GASTR NUTR, V52, P230, DOI 10.1097/MPG.0b013e3181f3d9ab
  19. Iborra M, 2011, J CROHNS COLITIS, V5, P157, DOI 10.1016/j.crohns.2010.11.001
  20. Kerbleski JF, 2009, GUT, V58, P1033, DOI 10.1136/gut.2008.163683
  21. Ko JM, 2009, J DERMATOL TREAT, V20, P100, DOI 10.1080/09546630802441234
  22. Laga AC, 2010, AM J DERMATOPATH, V32, P568, DOI 10.1097/DAD.0b013e3181cb3ff7
  23. Langley RG, 2010, BRIT J DERMATOL, V162, P1349, DOI 10.1111/j.1365-2133.2010.09707.x
  24. Manni E, 2009, INT J IMMUNOPATH PH, V22, P841
  25. Medkour F, 2010, GASTROEN CLIN BIOL, V34, P140, DOI 10.1016/j.gcb.2009.10.021
  26. Mocciaro F, 2009, AM J GASTROENTEROL, V104, P2867, DOI 10.1038/ajg.2009.396
  27. Najarian DJ, 2003, J AM ACAD DERMATOL, V48, P805, DOI 10.1067/mjd.2003.540
  28. Papadavid E, 2008, J EUR ACAD DERMATOL, V22, P380, DOI 10.1111/j.1468-3083.2007.02335.x
  29. Park BC, 2009, ANN DERMATOL, V21, P60, DOI 10.5021/ad.2009.21.1.60
  30. Passarini B, 2007, DERMATOLOGY, V215, P295, DOI 10.1159/000107622
  31. Peramiquel L, 2005, CLIN EXP DERMATOL, V30, P713, DOI 10.1111/j.1365-2230.2005.01882.x
  32. Perez-Perez L, 2008, ACTA DERM-VENEREOL, V88, P292, DOI 10.2340/00015555-0425
  33. Pirard D, 2006, DERMATOLOGY, V213, P182, DOI 10.1159/000095033
  34. Pourciau C, 2010, PEDIATR DERMATOL, V27, P539, DOI 10.1111/j.1525-1470.2010.01267.x
  35. Rahier JF, 2010, CLIN GASTROENTEROL H, V8, P1048, DOI 10.1016/j.cgh.2010.07.022
  36. Richetta A, 2008, Dermatol Online J, V14, P9
  37. Seneschal J, 2009, BRIT J DERMATOL, V161, P1081, DOI 10.1111/j.1365-2133.2009.09329.x
  38. Severs GA, 2007, CUTIS, V80, P231
  39. Takahashi H, 2007, J DERMATOL, V34, P468, DOI 10.1111/j.1346-8138.2007.00312.x
  40. Tichy M, 2012, J DERMATOL TREAT, V23, P208, DOI 10.3109/09546634.2010.521811
  41. Umeno J, 2007, INFLAMM BOWEL DIS, V13, P1188, DOI 10.1002/ibd.20150
  42. U.S. Food and Drug Administration, POSTM DRUG SAF INF P
  43. Verea MM, 2004, ANN PHARMACOTHER, V38, P54, DOI 10.1345/aph.1C477
  44. Viguier M, 2009, GAIT POSTURE, V29, P188, DOI 10.1016/j.gaitpost.2008.08.001
  45. Wermuth J, 2009, CLIN GASTROENTEROL H, V7, pXXVIII, DOI 10.1016/j.cgh.2008.08.009
  46. Wollina U, 2008, AM J CLIN DERMATOL, V9, P1

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC